Aytu BioPharma Reports Record Fourth Quarter and Fiscal Year 2022 Revenue
Yahoo! Finance
Aytu BioPharma, Inc. (Nasdaq:AYTU), a pharmaceutical company focused on commercializing novel therapeutics, with a development pipeline addressing rare, pediatric-onset disorders, today announced financial and operational results for the fourth quarter and fiscal year ended June 30, 2022.
Continue Reading